Martha Idalí Saboyá-Díaz1, Angel F Betanzos-Reyes2, Sheila K West3, Beatriz Muñoz3, Luis Gerardo Castellanos1, Marcos Espinal1. 1. Communicable Diseases and Environmental Determinants of Health Department Pan American Health Organization/World Health Organization Washington, DC United States of the America Communicable Diseases and Environmental Determinants of Health Department, Pan American Health Organization/World Health Organization, Washington, DC, United States of the America. 2. Centro de Investigación sobre Enfermedades Infecciosas Instituto Nacional de Salud Pública de México CuernavacaMorelos Mexico Centro de Investigación sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública de México, Cuernavaca, Morelos, Mexico. 3. Dana Center for Preventive Ophthalmology Wilmer Eye Institute, Johns Hopkins Hospital BaltimoreMaryland United States of America Dana Center for Preventive Ophthalmology, Wilmer Eye Institute, Johns Hopkins Hospital, Baltimore, Maryland, United States of America.
Abstract
OBJECTIVE: To identify and prioritize municipalities in 22 countries of Latin America for trachoma surveillance activities, to measure the absence or prevalence of trachoma, and to support validation and trachoma elimination efforts in the Region of the Americas. METHODS: A prioritization scale was developed in 2017 to rank each municipality by considering a combination of three characteristics: (a) its trachoma vulnerability index, derived from three socioeconomic factors known to be risks for trachoma-lack of access to improved sanitation, to clean drinking water, and to adequate education, according to housing census data from early 2017; (b) its history of trachoma in countries where the disease was not a known public health problem in 2016; and (c) whether or not it shares a border with a municipality where trachoma was a known public health problem in 2016. Municipalities in 22 countries were classified as either very high, high, medium, or low priority for trachoma surveillance. From the Caribbean, only Trinidad and Tobago met inclusion criteria. RESULTS: The prioritization scale identified 1 053 municipalities in Brazil, Colombia, and Guatemala as very high priority for trachoma surveillance. In Ecuador, El Salvador, Guyana, Paraguay, Peru, Suriname, and Venezuela, 183 municipalities were ranked as high priority, and in Argentina, Belize, Bolivia, Chile, Dominican Republic, Honduras, Nicaragua, Panama, and Uruguay, 677 municipalities were designated a medium priority for trachoma surveillance. CONCLUSIONS: This prioritization scale will be useful to countries in Latin America that still need to ascertain their current trachoma situation. The absence or prevalence of trachoma in countries designated as very high and high priority for trachoma surveillance activities must be studied to determine the extent of the disease in Latin America.
OBJECTIVE: To identify and prioritize municipalities in 22 countries of Latin America for trachoma surveillance activities, to measure the absence or prevalence of trachoma, and to support validation and trachoma elimination efforts in the Region of the Americas. METHODS: A prioritization scale was developed in 2017 to rank each municipality by considering a combination of three characteristics: (a) its trachoma vulnerability index, derived from three socioeconomic factors known to be risks for trachoma-lack of access to improved sanitation, to clean drinking water, and to adequate education, according to housing census data from early 2017; (b) its history of trachoma in countries where the disease was not a known public health problem in 2016; and (c) whether or not it shares a border with a municipality where trachoma was a known public health problem in 2016. Municipalities in 22 countries were classified as either very high, high, medium, or low priority for trachoma surveillance. From the Caribbean, only Trinidad and Tobago met inclusion criteria. RESULTS: The prioritization scale identified 1 053 municipalities in Brazil, Colombia, and Guatemala as very high priority for trachoma surveillance. In Ecuador, El Salvador, Guyana, Paraguay, Peru, Suriname, and Venezuela, 183 municipalities were ranked as high priority, and in Argentina, Belize, Bolivia, Chile, Dominican Republic, Honduras, Nicaragua, Panama, and Uruguay, 677 municipalities were designated a medium priority for trachoma surveillance. CONCLUSIONS: This prioritization scale will be useful to countries in Latin America that still need to ascertain their current trachoma situation. The absence or prevalence of trachoma in countries designated as very high and high priority for trachoma surveillance activities must be studied to determine the extent of the disease in Latin America.
Entities:
Keywords:
Latin America; Trachoma; neglected diseases; surveillance
Authors: Rosario Barrenechea; Inés de la Fuente; Roberto Gustavo Plaza; Nadia Flores; Lía Segovia; Zaida Villagómez; Esteban Elián Camarero; Luz Consuelo Zepeda-Romero; Van C Lansingh; Hans Limburg; Juan Carlos Silva Journal: Rev Panam Salud Publica Date: 2015-01
Authors: Anna Rius; Laura Guisasola; Meritxell Sabidó; Janet L Leasher; David Moriña; Astrid Villalobos; Van C Lansingh; Oscar J Mujica; José Eduardo Rivera-Handal; Juan Casrlos Silva Journal: Rev Panam Salud Publica Date: 2014-11
Authors: Doris Alvarado; Belinda Rivera; Luis Lagos; Mayra Ochoa; Ivette Starkman; Mariela Castillo; Eduardo Flores; Van C Lansingh; Hans Limburg; Juan Carlos Silva Journal: Rev Panam Salud Publica Date: 2014-11
Authors: Seth R Flaxman; Rupert R A Bourne; Serge Resnikoff; Peter Ackland; Tasanee Braithwaite; Maria V Cicinelli; Aditi Das; Jost B Jonas; Jill Keeffe; John H Kempen; Janet Leasher; Hans Limburg; Kovin Naidoo; Konrad Pesudovs; Alex Silvester; Gretchen A Stevens; Nina Tahhan; Tien Y Wong; Hugh R Taylor Journal: Lancet Glob Health Date: 2017-10-11 Impact factor: 26.763
Authors: E Brook Goodhew; Jeffrey W Priest; Delynn M Moss; Guangming Zhong; Beatriz Munoz; Harran Mkocha; Diana L Martin; Sheila K West; Charlotte Gaydos; Patrick J Lammie Journal: PLoS Negl Trop Dis Date: 2012-11-01
Authors: Meredith E Stocks; Stephanie Ogden; Danny Haddad; David G Addiss; Courtney McGuire; Matthew C Freeman Journal: PLoS Med Date: 2014-02-25 Impact factor: 11.069
Authors: Ana Nilce S Maia-Elkhoury; Daniel Magalhães Lima; Oscar Daniel Salomón; Lia Puppim Buzanovsky; Martha Idalí Saboyá-Díaz; Samantha Y O B Valadas; Manuel J Sanchez-Vazquez Journal: Rev Panam Salud Publica Date: 2021-04-28
Authors: Ana Nilce S Maia-Elkhoury; Daniel Magalhães Lima; Oscar Daniel Salomón; Lia Puppim Buzanovsky; Martha Idalí Saboyá-Díaz; Samantha Y O B Valadas; Manuel J Sanchez-Vazquez Journal: Rev Panam Salud Publica Date: 2021-07-01